|
|
||||||||
The Journal of Immunology, Vol 154, Issue 8 4166-4172, Copyright © 1995 by American Association of Immunologists
ARTICLES |
M Weber, M Uguccioni, B Ochensberger, M Baggiolini, I Clark-Lewis and CA Dahinden
Institute of Immunology and Allergology, Inselspital, Bern, Switzerland.
It has been shown that CC chemokines activate basophil and eosinophil leukocytes with different selectivities and patterns of activity. The most effective are monocyte chemotactic protein-1 (MCP-1), a potent stimulus of mediator release in basophils without effects on eosinophils, RANTES, a weak stimulus of release and strong chemoattractant for basophils and eosinophils, and MCP-3, which combines the activities of MCP-1 and RANTES. We have now compared MCP- 2, which has 62 and 60% of sequence identity with MCP-1 and MCP-3, respectively, with the other CC chemokines. MCP-2 induced mediator release by human basophils with lower efficacy and potency than MCP-1 and MCP-3. It promoted transient changes of cytosolic-free calcium concentration ([Ca2+]i) and chemotactic responses in both basophils and eosinophils, however somewhat less efficiently than MCP-3 and RANTES. Desensitization studies indicate that MCP-2 interacts with receptors recognizing MCP-1 as well as RANTES. These results demonstrate that MCP- 2 and MCP-3 exert qualitatively similar biologic activities on basophils and eosinophils. In basophils that had not been treated with IL-3, MCP-2 induced minimal exocytosis only, but desensitized the cells toward MCP-1 and MCP-3, suggesting that MCP-2 may act as a functional inhibitor of CC chemokine actions. The results of this study further indicate that MCP analogues display partially distinct, partially overlapping bioactivities toward eosinophils and basophils, and may thus regulate inflammatory processes involving these effector cell types.
This article has been cited by other articles:
![]() |
A. Tone, K. Shikata, D. Ogawa, S. Sasaki, R. Nagase, M. Sasaki, K. Yozai, H. Kataoka Usui, S. Okada, J. Wada, et al. Changes of gene expression profiles in macrophages stimulated by angiotensin II -- Angiotensin II induces MCP-2 through AT1-receptor Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 45 - 50. [Abstract] [PDF] |
||||
![]() |
D. E. Sloane, N. Tedla, M. Awoniyi, D. W. MacGlashan Jr, L. Borges, K. F. Austen, and J. P. Arm Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition Blood, November 1, 2004; 104(9): 2832 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kehlen, U. Lendeckel, H. Dralle, J. Langner, and C. Hoang-Vu Biological Significance of Aminopeptidase N/CD13 in Thyroid Carcinomas Cancer Res., December 1, 2003; 63(23): 8500 - 8506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Borchers, T. Ansay, R. DeSalle, B. L. Daugherty, H. Shen, M. Metzger, N. A. Lee, and J. J. Lee In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration J. Leukoc. Biol., June 1, 2002; 71(6): 1033 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hoeck and M. Woisetschlager Activation of Eotaxin-3/CCL26 Gene Expression in Human Dermal Fibroblasts Is Mediated by STAT6 J. Immunol., September 15, 2001; 167(6): 3216 - 3222. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Asselin, G. A. Johnson, T. E. Spencer, and F. W. Bazer Monocyte Chemotactic Protein-1 and -2 Messenger Ribonucleic Acids in the Ovine Uterus: Regulation by Pregnancy, Progesterone, and Interferon-{{tau}} Biol Reprod, March 1, 2001; 64(3): 992 - 1000. [Abstract] [Full Text] |
||||
![]() |
A. Heinemann, A. Hartnell, V. E. L. Stubbs, K. Murakami, D. Soler, G. LaRosa, P. W. Askenase, T. J. Williams, and I. Sabroe Basophil Responses to Chemokines Are Regulated by Both Sequential and Cooperative Receptor Signaling J. Immunol., December 15, 2000; 165(12): 7224 - 7233. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M A. El-Asrar, S. Struyf, S. A Al-Kharashi, L. Missotten, J. Van Damme, and K. Geboes Chemokines in the limbal form of vernal keratoconjunctivitis Br. J. Ophthalmol., December 1, 2000; 84(12): 1360 - 1366. [Abstract] [Full Text] |
||||
![]() |
G. T. Kampen, S. Stafford, T. Adachi, T. Jinquan, S. Quan, J. A. Grant, P. S. Skov, L. K. Poulsen, and R. Alam Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases Blood, March 15, 2000; 95(6): 1911 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ying, D. S. Robinson, Q. Meng, L. T. Barata, A. R. McEuen, M. G. Buckley, A. F. Walls, P. W. Askenase, and A. B. Kay C-C Chemokines in Allergen-Induced Late-Phase Cutaneous Responses in Atopic Subjects: Association of Eotaxin with Early 6-Hour Eosinophils, and of Eotaxin-2 and Monocyte Chemoattractant Protein-4 with the Later 24-Hour Tissue Eosinophilia, and Relationship to Basophils and Other C-C Chemokines (Monocyte Chemoattractant Protein-3 and RANTES) J. Immunol., October 1, 1999; 163(7): 3976 - 3984. [Abstract] [Full Text] [PDF] |
||||
![]() |
K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text] |
||||
![]() |
A. Shinkai, H. Yoshisue, M. Koike, E. Shoji, S. Nakagawa, A. Saito, T. Takeda, S. Imabeppu, Y. Kato, N. Hanai, et al. A Novel Human CC Chemokine, Eotaxin-3, Which Is Expressed in IL-4-Stimulated Vascular Endothelial Cells, Exhibits Potent Activity Toward Eosinophils J. Immunol., August 1, 1999; 163(3): 1602 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wong and E. N. Fish RANTES and MIP-1alpha Activate Stats in T Cells J. Biol. Chem., January 2, 1998; 273(1): 309 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Sarau, J. A. Rush, J. J. Foley, M. E. Brawner, D. B. Schmidt, J. R. White, and M. S. Barnette Characterization of Functional Chemokine Receptors (CCR1 and CCR2) on EoL-3 Cells: A Model System to Examine the Role of Chemokines in Cell Function J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 411 - 418. [Abstract] [Full Text] |
||||
![]() |
B. J. Rollins Chemokines Blood, August 1, 1997; 90(3): 909 - 928. [Full Text] [PDF] |
||||
![]() |
U. Forssmann, M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes J. Exp. Med., June 16, 1997; 185(12): 2171 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gong, W. Gong, D. B. Kuhns, A. Ben-Baruch, O. M. Z. Howard, and J. M. Wang Monocyte Chemotactic Protein-2 (MCP-2) Uses CCR1 AND CCR2B as Its Functional Receptors J. Biol. Chem., May 2, 1997; 272(18): 11682 - 11685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Sarafi, E. A. Garcia-Zepeda, J. A. MacLean, I. F. Charo, and A. D. Luster Murine Monocyte Chemoattractant Protein (MCP)-5: A Novel CC Chemokine That Is a Structural and Functional Homologue of Human MCP-1 J. Exp. Med., January 1, 1997; 185(1): 99 - 110. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |